Citi Reduces PT on GE HealthCare Technologies (GEHC) Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) is one of the Most Undervalued Stocks to Buy According to Analysts. On March 12, Citi reduced its price objective on the company’s stock to $84 from $88, while keeping a “Neutral” rating, as reported by The Fly. Notably, the firm adjusted its targets in the broader medical technology group after Q4 reports. As per the analyst, the fundamentals are strong for the broader sector despite the current volatility.

Citi Reduces PT on GE HealthCare Technologies (GEHC) Stock

In a different update, GE HealthCare Technologies Inc. (NASDAQ:GEHC) announced that View received 510(k) clearance from the US FDA. View is a powerful viewer within the Genesis™ Radiology Workspace. As per the company, the next‑generation solution focuses on transforming radiology workflows, unifying the user experience, and enabling radiologists with increased efficiency and precision.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) highlighted that up to 44% of the time is spent on non-interpretive tasks by radiologists. The company aims to remove traditional infrastructure barriers, which can result in faster collaboration and more streamlined workflows.

GE HealthCare Technologies Inc. (NASDAQ:GEHC) operates within the pharmaceutical diagnostics and medical technology spaces. With a focus on precision care, it develops and markets products along with additional services that are used in the diagnosis, treatment, and monitoring of patients.

While we acknowledge the risk and potential of GEHC as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than GEHC and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Best FMCG Stocks to Invest In According to Analysts and 11 Best Long-Term Tech Stocks to Buy According to Analysts.

Disclosure: None. Follow Insider Monkey on Google News.